Jose Nativi-Nicolau, M.D.

Schedule An Appointment	Clinical Office Address
(800) 332-7156	Billings Clinic 1020 North 27th Street Billings, MT 59107
(208) 367-4278	Saint Alphonsus Regional Medical Center 6140 West Curtisian , Ste. 200 Boise, ID 83706
(801) 585-5122	University Hospital Heart Failure Clinic 50 N Medical Dr Salt Lake City, UT 84132 Map
(801) 585-3693	University Hospital Heart Transplant Clinic 50 N Medical Dr Salt Lake City, UT 84132 Map
(801) 584-1235	Veterans Administration Medical Center 500 S Foothill Blvd Salt Lake City, UT 84149

Bio

Dr. Nativi-Nicolau is an Assistant Professor of Medicine at the University of Utah and is the Cardiovascular Director of the Amyloidosis Program at the University of Utah and Huntsman Cancer Institute.

He received his medical degree from University of Panama. Dr. Nativi-Nicolau completed his Internal Medicine Residency at Drexel University College of Medicine in Philadelphia, Pennsylvania. He accomplished his Cardiology Fellowship at the University of Utah in Salt Lake City. He continued his training with an Advanced Heart Failure and Transplantation Fellowship at the Mayo Clinic in Rochester Minnesota. Dr. Nativi-Nicolau He is board certified in Internal Medicine, Cardiovascular Disease, and Advanced Heart Failure and Transplantation and is a member of the Alpha-Omega-Alpha American Honor Medical Society.

His clinical and research interest includes cardiac amyloidosis, heart failure, mechanical circulatory support and heart transplantation.

Board Certification and Academic Information

Academic Departments	Internal Medicine - Assistant Professor
Academic Divisions	Cardiovascular Medicine
Board Certification	American Board of Internal Medicine (Internal Medicine) American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology) American Board of Internal Medicine (Sub: Cardiovascular Disease) National Board of Medical Examiners

Board Certification and Academic Information

Academic Departments	Internal Medicine - Assistant Professor
Academic Divisions	Cardiovascular Medicine
Board Certification	American Board of Internal Medicine (Internal Medicine) American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology) American Board of Internal Medicine (Sub: Cardiovascular Disease) National Board of Medical Examiners

Academic Office Locations

Academic Office Phone Number	Academic Office Address
(801) 585-2340	School of Medicine Division of Cardiovascular Medicine 30 N 1900 E Salt Lake City, UT 84132

Academic Bio

Dr. Nativi-Nicolau is an Assistant Professor of Medicine at the University of Utah. He received his medical degree from University of Panama. Dr. Nativi-Nicolau completed his Internal Medicine Residency at Drexel University College of Medicine in Philadelphia, Pennsylvania. He accomplished his Cardiology Fellowship at the University of Utah in Salt Lake City. He continued his training with an Advanced Heart Failure and Transplantation Fellowship at the Mayo Clinic in Rochester Minnesota.

Dr. Nativi-Nicolau is the Cardiovascular Director of the Amyloidosis Program at the University of Utah and Huntsman Cancer Institute. He is board certified in Internal Medicine, Cardiovascular Disease, and Advanced Heart Failure and Transplantation and is a member of the Alpha-Omega-Alpha American Honor Medical Society.

His clinical and research interest includes cardiac amyloidosis, heart failure, mechanical circulatory support and heart transplantation.

Education History

Type	School	Degree
Graduate Training	University of Utah Clinical Investigation	M.S.
Fellowship	Mayo Clinic Advanced Heart Failure	Fellow
Fellowship	University of Utah Cardiovascular Disease	Fellow
Residency	Drexel University College of Medicine Internal Medicine	Resident
Internship	Drexel University College of Medicine Internal Medicine	Intern
Internship	Dionisio Arrocha Hospital Second Year	Transitional Internship
Internship	Metropolitan Hospital First Year	Transitional Internship
Professional Medical	University of Panama Medicine	M.D.

Selected Provider Publications

Journal Article

1. Nativi-Nicolau J, Ryan J, Fang J (2014). Current therapeutic approach in Heart Failure with Preserved Ejection Fraction. Heart Failure Clinics, 10, 525-538.
2. Nativi-Nicolau J, Selzman C, Fang J, Stehlik J (2014). Pharmacological therapies in acute cardiogenic shock patients. Curr Opin Cardiol, 29, 250.
3. Barrett-OKeefe Z, Lee JF, Berbert A, Witman MA, Nativi JN, Stehlik J, Richardson RS, Wray DW (2014). Hemodynamic Responses to Small Muscle Mass Exercise in Heart Failure Patients with Reduced Ejection Fraction. Am J Physiol Heart Circ Physiol, 307(10), H1512-20.
4. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J (2013). Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation, 127(4), 452-62.
5. Witman MA, McDaniel J, Fjeldstad AS, Ives SJ, Zhao J, Nativi JN, Stehlik J, Wray DW, Richardson RS (2012). A differing role of oxidative stress in the regulation of central and peripheral hemodynamics during exercise in heart failure. Am J Physiol Heart Circ Physiol, 303(10), H1237-44.
6. Witman MA, Fjeldstad AS, McDaniel J, Ives SJ, Zhao J, Barrett-OKeefe Z, Nativi JN, Stehlik J, Wray DW, Richardson RS (2012). Vascular function and the role of oxidative stress in heart failure, heart transplant, and beyond. Hypertension, 60(3), 659-68.
7. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J (2011). Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant, 11(12), 2755-61.
8. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J (2011). Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 30(8), 854-61.
9. Hayman MA, Nativi JN, Stehlik J, McDaniel J, Fjeldstad AS, Ives SJ, Walter Wray D, Bader F, Gilbert EM, Richardson RS (2010). Understanding exercise-induced hyperemia: central and peripheral hemodynamic responses to passive limb movement in heart transplant recipients. Am J Physiol Heart Circ Physiol, 299(5), H1653-9.
10. Nativi JN, Brown RN, Taylor DO, Kfoury AG, Kirklin JK, Stehlik J (2010). Temporal trends in heart transplantation from high-risk donors: are there lessons to be learned? A multi-institutional analysis. J Heart Lung Transplant, 29(8), 847-52.
11. Nativi JN, Kfoury AG, Myrick C, Peters M, Renlund D, Gilbert EM, Bader F, Singhal AK, Everitt M, Fisher P, Bull DA, Selzman C, Stehlik J (2010). Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. J Heart Lung Transplant, 29(3), 235-9.

Clinical Trials

• NEAT HFpEF
  Keywords: Heart Failure, Preserved Ejection Fraction, HFpEF, Nitrates, Activity Tolerance
  Status: Not yet recruiting Principal Investigator: Jose Nativi-Nicolau